Clinical Trial

Ligufalimab and Cadonilimab in Advanced Liver Cancers

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to find out if the combination of Ligufalimab and Cadonilimab are effective in treating advanced hepatobiliary cancers that have failed prior therapy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-01-21; most recent amendment 2026-02-25.
Status change: Not Yet Recruiting → Recruiting 2025-02-19
Trial Details
NCT Number NCT06789848
Lead Sponsor University of Texas Southwestern Medical Center
Collaborators: Akesobio, Josephine Hughes Sterling Foundation
Conditions Advanced Hepatocellular Carcinoma, Refractory Hepatocellular Carcinoma, Biliary Tract Cancer
Enrollment 64 participants
Start Date 2025-02-18
Primary Completion 2029-05-31 (estimated)
Study Completion 2030-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-27